Hypouricemic effect of the methanol extract from Prunus mume fruit in mice

Li-Tao Yi1, Jing Li, Dong-Xue Su

  • 1Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian province, PR China. litaoyi@hqu.edu.cn

Pharmaceutical Biology
|August 4, 2012
PubMed
Abstract

Insights

Prunus mume fruit extract (MPMF) effectively lowered uric acid levels in hyperuricemic mice. This hypouricemic effect is linked to the inhibition of liver xanthine oxidase (XO) activity, suggesting potential as an anti-gout agent.

Area of Science:

  • Pharmacology
  • Natural Products Research
  • Traditional Medicine

Background:

  • Prunus mume fruit is traditionally used in Eastern Asian medicine.
  • It is recognized for its health benefits and medicinal properties.

Purpose of the Study:

  • To investigate the hypouricemic (uric acid-lowering) effect of Prunus mume methanol extract (MPMF).
  • To assess the impact of MPMF on hyperuricemia induced by potassium oxonate in a mouse model.

Main Methods:

  • Mice were administered varying doses of MPMF (35, 70, 140 mg/kg) orally for seven days.
  • Serum, liver, and urinary uric acid levels were measured.
  • Liver xanthine oxidase (XO) activity was assessed.

Main Results:

  • Potassium oxonate induced elevated serum and liver uric acid and reduced urinary uric acid.
  • MPMF administration, particularly at 140 mg/kg, normalized these uric acid levels.
  • MPMF (70 and 140 mg/kg) significantly inhibited liver XO activity.

Conclusions:

  • MPMF demonstrates a hypouricemic effect in mice, likely through the inhibition of liver XO activity.
  • Prunus mume extracts show potential for development as a natural anti-gout therapeutic agent.

Related Concept Videos